2024 Q3 Form 10-Q Financial Statement

#000165495424010636 Filed on August 14, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2024 Q2
Revenue $2.012M $1.727M
YoY Change 53.18% 31.8%
Cost Of Revenue $806.1K $751.2K
YoY Change 73.13% 51.91%
Gross Profit $1.206M $975.4K
YoY Change 42.23% 19.6%
Gross Profit Margin 59.93% 56.49%
Selling, General & Admin $1.474M $1.504M
YoY Change -3.8% -4.35%
% of Gross Profit 122.25% 154.22%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $335.5K $277.9K
YoY Change 76.57% 46.18%
% of Gross Profit 27.83% 28.49%
Operating Expenses $1.691M $1.735M
YoY Change -69.74% -18.32%
Operating Profit -$485.5K -$759.1K
YoY Change -89.76% -41.96%
Interest Expense -$20.13K -$23.78K
YoY Change -301.26% -394.31%
% of Operating Profit
Other Income/Expense, Net -$12.28K -$22.62K
YoY Change -264.54% -262.7%
Pretax Income -$497.8K -$781.7K
YoY Change -89.48% -39.59%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$497.8K -$781.7K
YoY Change -89.48% -39.59%
Net Earnings / Revenue -24.74% -45.28%
Basic Earnings Per Share
Diluted Earnings Per Share -$0.11 -$0.17
COMMON SHARES
Basic Shares Outstanding 5.127M shares 5.107M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2024 Q3 2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $363.2K $310.0K
YoY Change -89.22% -92.35%
Cash & Equivalents $363.2K $310.0K
Short-Term Investments
Other Short-Term Assets $155.3K $164.6K
YoY Change 29.43% 0.15%
Inventory $55.33K $84.59K
Prepaid Expenses
Receivables $226.7K $264.9K
Other Receivables $0.00 $0.00
Total Short-Term Assets $800.5K $824.1K
YoY Change -78.4% -81.44%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill $3.113M $3.096M
YoY Change 167.06% -27.05%
Intangibles $4.070M $4.398M
YoY Change 24.07% 5.07%
Long-Term Investments $267.5K $266.8K
YoY Change -2.65% -3.73%
Other Assets $136.3K $121.3K
YoY Change -14.79% -6.34%
Total Long-Term Assets $7.775M $8.085M
YoY Change 54.52% -10.07%
TOTAL ASSETS
Total Short-Term Assets $800.5K $824.1K
Total Long-Term Assets $7.775M $8.085M
Total Assets $8.575M $8.909M
YoY Change -1.87% -33.67%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $786.7K $703.5K
YoY Change 82.96% 99.73%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $311.6K $0.00
YoY Change -100.0%
Long-Term Debt Due $128.7K
YoY Change -94.67%
Total Short-Term Liabilities $3.350M $3.016M
YoY Change 5.15% -3.99%
LONG-TERM LIABILITIES
Long-Term Debt $1.039M $1.089M
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $1.039M $1.089M
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $3.350M $3.016M
Total Long-Term Liabilities $1.039M $1.089M
Total Liabilities $4.389M $4.105M
YoY Change 37.76% 30.67%
SHAREHOLDERS EQUITY
Retained Earnings -$18.11M -$17.53M
YoY Change 20.33% 70.85%
Common Stock $5.128K $118.00
YoY Change -98.77% -99.97%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $3.882M $4.483M
YoY Change
Total Liabilities & Shareholders Equity $8.575M $8.909M
YoY Change -1.87% -33.67%

Cashflow Statement

Concept 2024 Q3 2024 Q2
OPERATING ACTIVITIES
Net Income -$497.8K -$781.7K
YoY Change -89.48% -39.59%
Depreciation, Depletion And Amortization $335.5K $277.9K
YoY Change 76.57% 46.18%
Cash From Operating Activities $67.03K -$332.7K
YoY Change -111.17% -37.71%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 -$54.00K
YoY Change
Cash From Investing Activities $0.00 -$54.00K
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 64.47K 151.6K
YoY Change -192.1% -338.87%
NET CHANGE
Cash From Operating Activities 67.03K -332.7K
Cash From Investing Activities 0.000 -54.00K
Cash From Financing Activities 64.47K 151.6K
Net Change In Cash 131.5K -235.1K
YoY Change -119.63% -60.66%
FREE CASH FLOW
Cash From Operating Activities $67.03K -$332.7K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Share Based Compensation
ShareBasedCompensation
483597 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-6217 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
12095 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
555802 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
361108 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
174807 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-31241 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-8051 usd
us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
53532 usd
us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
-47791 usd
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
209661 usd
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
-198231 usd
onfo Increase Decrease In Due To Joint Ventures
IncreaseDecreaseInDueToJointVentures
-17806 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
22045 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
134071 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-763747 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1556175 usd
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
850000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-304000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-850000 usd
onfo Proceeds From Sale Of Series A Preferred Stock
ProceedsFromSaleOfSeriesAPreferredStock
10000 usd
onfo Proceeds From Sale Of Series A Preferred Stock
ProceedsFromSaleOfSeriesAPreferredStock
0 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-2648767 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
982261 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6701122 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4052355 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
us-gaap Interest Paid Net
InterestPaidNet
41700 usd
us-gaap Interest Paid Net
InterestPaidNet
18836 usd
us-gaap Profit Loss
ProfitLoss
-2578200 usd
us-gaap Share Based Compensation
ShareBasedCompensation
45397 usd
onfo Dividends Received From Equity Method Investment
DividendsReceivedFromEquityMethodInvestment
0 usd
onfo Dividends Received From Equity Method Investment
DividendsReceivedFromEquityMethodInvestment
-15266 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
12854 usd
onfo Increase Decrease In Due To Joint Ventures
IncreaseDecreaseInDueToJointVentures
29653 usd
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
255000 usd
us-gaap Payments Of Dividends
PaymentsOfDividends
151035 usd
us-gaap Payments Of Dividends
PaymentsOfDividends
109053 usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
417900 usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
0 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
56516 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
49744 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-415749 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-198797 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-20238 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-43795 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-672236 usd
onfo Issuance Of Promissory Note For Acquisition
IssuanceOfPromissoryNoteForAcquisition
640000 usd
onfo Issuance Of Promissory Note For Acquisition
IssuanceOfPromissoryNoteForAcquisition
0 usd
onfo Issuance Of Preferred Stock For Acquisition
IssuanceOfPreferredStockForAcquisition
625000 usd
onfo Issuance Of Preferred Stock For Acquisition
IssuanceOfPreferredStockForAcquisition
0 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
666876 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
1323029 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
927003 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
347770 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
451881 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
247637 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
3964196 usd
us-gaap Incremental Common Shares Attributable To Contingently Issuable Shares
IncrementalCommonSharesAttributableToContingentlyIssuableShares
8000 shares
us-gaap Dividends
Dividends
166113 usd
us-gaap Payments Of Dividends
PaymentsOfDividends
151035 usd
CY2024Q2 onfo Unpaid Dividends
UnpaidDividends
83089 usd
CY2023Q4 onfo Unpaid Dividends
UnpaidDividends
68011 usd
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q1 us-gaap Debt Instrument Description
DebtInstrumentDescription
the principal sum of $440,000, matures on December 31, 2025, and interest on the outstanding principal balance of, and all other sums owing under the loan amount, is 11%. Upon the occurrence of an Event of Default (as defined in the RevenueZen Note), the interest rate automatically increases to the rate of 16% per annum. The loan amount is payable as follows: (i) commencing on the date that was thirty (30) days from the date of the RevenueZenNote and continuing monthly on such same day thereafter, the Company shall make an interest only payment equal to $4,033 per month and commencing on July 31, 2024 the Company shall make an interest only payment of $3,575 per month (ii) no later than June 30, 2024, the Company must make a payment of $50,000; and (iii) the entire loan amount, together with all accrued but unpaid interest thereon, shall be due and payable on the Maturity Date
us-gaap Debt Instrument Periodic Payment
DebtInstrumentPeriodicPayment
12933 usd
us-gaap Repayments Of Other Debt
RepaymentsOfOtherDebt
116400 usd
CY2024Q2 onfo Ompany Owed
ompanyOwed
43484 usd
CY2024Q2 onfo Distribution To Non Controlling Interest
DistributionToNonControllingInterest
-3600 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-781737 usd
CY2024Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
4803472 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
12472435 usd
CY2023Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
233355 usd
CY2023Q1 onfo Preferred Dividends
PreferredDividends
-51025 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-7481 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-1284075 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
11363209 usd
CY2023Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
250242 usd
CY2023Q2 onfo Preferred Dividends
PreferredDividends
-50244 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
20067 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-1294125 usd
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
10289149 usd
us-gaap Profit Loss
ProfitLoss
-1412234 usd
us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0 usd
us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
189937 usd
onfo Cash Paid For Cost Method Investments
CashPaidForCostMethodInvestments
49000 usd
onfo Cash Paid For Cost Method Investments
CashPaidForCostMethodInvestments
0 usd
onfo Distributions To Non Controlling Interest Holders
DistributionsToNonControllingInterestHolders
3600 usd
onfo Distributions To Non Controlling Interest Holders
DistributionsToNonControllingInterestHolders
0 usd
us-gaap Payments For Previous Acquisition
PaymentsForPreviousAcquisition
0 usd
us-gaap Payments For Previous Acquisition
PaymentsForPreviousAcquisition
40000 usd
onfo Proceeds From Notes Payable Related Parties
ProceedsFromNotesPayableRelatedParties
200000 usd
onfo Proceeds From Notes Payable Related Parties
ProceedsFromNotesPayableRelatedParties
0 usd
dei Entity Central Index Key
EntityCentralIndexKey
0001825452
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Entity Address Address Line2
EntityAddressAddressLine2
4th Floor
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5127395 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5107395 shares
us-gaap Dividends Share Based Compensation
DividendsShareBasedCompensation
483597 usd
us-gaap Dividends Share Based Compensation
DividendsShareBasedCompensation
45397 usd
CY2023Q4 us-gaap Common Unit Authorized
CommonUnitAuthorized
50000000 shares
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-41466
dei Entity Registrant Name
EntityRegistrantName
ONFOLIO HOLDINGS INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
37-1978697
dei Entity Address Address Line1
EntityAddressAddressLine1
1007 North Orange Street, 4th Floor
dei Entity Address City Or Town
EntityAddressCityOrTown
Wilmington
dei Entity Address State Or Province
EntityAddressStateOrProvince
DE
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
19801
dei City Area Code
CityAreaCode
682
dei Local Phone Number
LocalPhoneNumber
990-6920
dei Security12b Title
Security12bTitle
Common stock, $0.001 par value
dei Trading Symbol
TradingSymbol
ONFO
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
5127396 shares
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
310025 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
982261 usd
CY2024Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
264877 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
90070 usd
CY2024Q2 us-gaap Inventory Net
InventoryNet
84586 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
92637 usd
CY2024Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
164629 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
111097 usd
CY2024Q2 us-gaap Assets Current
AssetsCurrent
824117 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
1276065 usd
CY2024Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
4397519 usd
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
3110204 usd
CY2024Q2 us-gaap Goodwill
Goodwill
3095969 usd
CY2023Q4 us-gaap Goodwill
Goodwill
1167194 usd
CY2024Q2 onfo Due From Related Party
DueFromRelatedParty
121318 usd
CY2023Q4 onfo Due From Related Party
DueFromRelatedParty
150971 usd
CY2024Q2 us-gaap Long Term Investments
LongTermInvestments
203007 usd
CY2023Q4 us-gaap Long Term Investments
LongTermInvestments
154007 usd
CY2024Q2 us-gaap Equity Method Investments
EquityMethodInvestments
266825 usd
CY2023Q4 us-gaap Equity Method Investments
EquityMethodInvestments
273042 usd
CY2024Q2 us-gaap Assets
Assets
8908755 usd
CY2023Q4 us-gaap Assets
Assets
6131483 usd
CY2024Q2 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
703477 usd
CY2023Q4 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
493816 usd
CY2024Q2 us-gaap Dividends Payable Current
DividendsPayableCurrent
83089 usd
CY2023Q4 us-gaap Dividends Payable Current
DividendsPayableCurrent
68011 usd
CY2024Q2 us-gaap Notes Payable Current
NotesPayableCurrent
128707 usd
CY2023Q4 us-gaap Notes Payable Current
NotesPayableCurrent
17323 usd
CY2024Q2 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
1929000 usd
CY2023Q4 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
60000 usd
CY2024Q2 us-gaap Deferred Revenue
DeferredRevenue
172010 usd
CY2023Q4 us-gaap Deferred Revenue
DeferredRevenue
149965 usd
CY2024Q2 us-gaap Liabilities Current
LiabilitiesCurrent
3016283 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
789115 usd
CY2024Q2 us-gaap Long Term Notes Payable
LongTermNotesPayable
890000 usd
CY2023Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
0 usd
CY2024Q2 onfo Notes Payable Related Parties
NotesPayableRelatedParties
199000 usd
CY2023Q4 onfo Notes Payable Related Parties
NotesPayableRelatedParties
0 usd
CY2024Q2 us-gaap Liabilities
Liabilities
4105283 usd
CY2023Q4 us-gaap Liabilities
Liabilities
789115 usd
CY2024Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2024Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2024Q2 us-gaap Common Stock Value
CommonStockValue
118 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
93 usd
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2024Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5127395 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5107395 shares
CY2024Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
21847663 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
21107311 usd
CY2024Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
159119 usd
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
182465 usd
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-17529038 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-15952609 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
4482990 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
5342368 usd
CY2024Q2 us-gaap Members Equity Attributable To Noncontrolling Interest
MembersEquityAttributableToNoncontrollingInterest
320482 usd
CY2023Q4 us-gaap Members Equity Attributable To Noncontrolling Interest
MembersEquityAttributableToNoncontrollingInterest
0 usd
CY2024Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
4803472 usd
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
5342368 usd
CY2024Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
8908755 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
6131483 usd
CY2024Q2 onfo Revenue From Services
RevenueFromServices
993166 usd
CY2023Q2 onfo Revenue From Services
RevenueFromServices
295750 usd
onfo Revenue From Services
RevenueFromServices
1716717 usd
onfo Revenue From Services
RevenueFromServices
688151 usd
CY2024Q2 onfo Revenue From Product Sales
RevenueFromProductSales
733433 usd
CY2023Q2 onfo Revenue From Product Sales
RevenueFromProductSales
1014293 usd
onfo Revenue From Product Sales
RevenueFromProductSales
1596784 usd
onfo Revenue From Product Sales
RevenueFromProductSales
1973626 usd
CY2024Q2 us-gaap Revenues
Revenues
1726599 usd
CY2023Q2 us-gaap Revenues
Revenues
1310043 usd
us-gaap Revenues
Revenues
3313501 usd
us-gaap Revenues
Revenues
2661777 usd
CY2024Q2 onfo Cost Of Revenue On Services
CostOfRevenueOnServices
557518 usd
CY2023Q2 onfo Cost Of Revenue On Services
CostOfRevenueOnServices
129622 usd
onfo Cost Of Revenue On Services
CostOfRevenueOnServices
924224 usd
onfo Cost Of Revenue On Services
CostOfRevenueOnServices
433786 usd
CY2024Q2 onfo Cost Of Revenue On Product Sales
CostOfRevenueOnProductSales
193650 usd
CY2023Q2 onfo Cost Of Revenue On Product Sales
CostOfRevenueOnProductSales
364850 usd
onfo Cost Of Revenue On Product Sales
CostOfRevenueOnProductSales
409510 usd
onfo Cost Of Revenue On Product Sales
CostOfRevenueOnProductSales
669207 usd
CY2024Q2 us-gaap Cost Of Revenue
CostOfRevenue
751168 usd
CY2023Q2 us-gaap Cost Of Revenue
CostOfRevenue
494472 usd
us-gaap Cost Of Revenue
CostOfRevenue
1333734 usd
us-gaap Cost Of Revenue
CostOfRevenue
1102993 usd
CY2024Q2 us-gaap Gross Profit
GrossProfit
975431 usd
CY2023Q2 us-gaap Gross Profit
GrossProfit
815571 usd
us-gaap Gross Profit
GrossProfit
1979767 usd
us-gaap Gross Profit
GrossProfit
1558784 usd
CY2024Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1504349 usd
CY2023Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1572825 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2842204 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3192205 usd
CY2024Q2 us-gaap Professional Fees
ProfessionalFees
221255 usd
CY2023Q2 us-gaap Professional Fees
ProfessionalFees
303443 usd
us-gaap Professional Fees
ProfessionalFees
401445 usd
us-gaap Professional Fees
ProfessionalFees
627828 usd
CY2024Q2 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0 usd
CY2023Q2 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
189937 usd
us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0 usd
us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
189937 usd
CY2024Q2 us-gaap Acquisition Costs
AcquisitionCosts
8946 usd
CY2023Q2 us-gaap Acquisition Costs
AcquisitionCosts
57393 usd
us-gaap Acquisition Costs
AcquisitionCosts
103287 usd
us-gaap Acquisition Costs
AcquisitionCosts
208007 usd
CY2024Q2 us-gaap Operating Expenses
OperatingExpenses
1734550 usd
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
2123598 usd
us-gaap Operating Expenses
OperatingExpenses
3346936 usd
us-gaap Operating Expenses
OperatingExpenses
4217977 usd
CY2024Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-759119 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-1308027 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-1367169 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-2659193 usd
CY2024Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-1063 usd
CY2023Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
5207 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-6217 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
12095 usd
CY2024Q2 us-gaap Other Interest And Dividend Income
OtherInterestAndDividendIncome
0 usd
CY2023Q2 us-gaap Other Interest And Dividend Income
OtherInterestAndDividendIncome
247 usd
us-gaap Other Interest And Dividend Income
OtherInterestAndDividendIncome
0 usd
us-gaap Other Interest And Dividend Income
OtherInterestAndDividendIncome
1516 usd
CY2024Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-22718 usd
CY2023Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
2626 usd
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-40438 usd
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
58758 usd
CY2024Q2 us-gaap Other Income
OtherIncome
1163 usd
CY2023Q2 us-gaap Other Income
OtherIncome
5822 usd
us-gaap Other Income
OtherIncome
1590 usd
us-gaap Other Income
OtherIncome
8624 usd
CY2024Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-22618 usd
CY2023Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
13902 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-45065 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
80993 usd
CY2024Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-781737 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1294125 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1412234 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2578200 usd
CY2024Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-781737 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-1294125 usd
us-gaap Net Income Loss
NetIncomeLoss
-1412234 usd
us-gaap Net Income Loss
NetIncomeLoss
-2578200 usd
CY2024Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
1254 usd
CY2023Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
0 usd
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
1918 usd
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
0 usd
CY2024Q2 onfo Income Loss Attributables To Parent
IncomeLossAttributablesToParent
-780483 usd
CY2023Q2 onfo Income Loss Attributables To Parent
IncomeLossAttributablesToParent
-1294125 usd
onfo Income Loss Attributables To Parent
IncomeLossAttributablesToParent
-1410316 usd
onfo Income Loss Attributables To Parent
IncomeLossAttributablesToParent
-2578200 usd
CY2024Q2 us-gaap Dividends Preferred Stock
DividendsPreferredStock
84468 usd
CY2023Q2 us-gaap Dividends Preferred Stock
DividendsPreferredStock
50244 usd
us-gaap Dividends Preferred Stock
DividendsPreferredStock
166113 usd
us-gaap Dividends Preferred Stock
DividendsPreferredStock
101269 usd
CY2024Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-864951 usd
CY2023Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-1344369 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-1576429 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-2679469 usd
CY2024Q2 onfo Earning Per Share Basic And Diluted
EarningPerShareBasicAndDiluted
-0.17
CY2023Q2 onfo Earning Per Share Basic And Diluted
EarningPerShareBasicAndDiluted
-0.26
onfo Earning Per Share Basic And Diluted
EarningPerShareBasicAndDiluted
-0.31
onfo Earning Per Share Basic And Diluted
EarningPerShareBasicAndDiluted
-0.52
CY2024Q2 onfo Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
5109373 shares
CY2023Q2 onfo Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
5110195 shares
onfo Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
5108384 shares
onfo Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
5110195 shares
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
5342368 usd
CY2024Q1 onfo Acquisition Of Business Amount
AcquisitionOfBusinessAmount
611000 usd
CY2024Q1 onfo Sale Of Preferred Stock For Cash Amount
SaleOfPreferredStockForCashAmount
10000 usd
CY2024Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
17887 usd
CY2024Q1 onfo Warrants Issued For Acquisition
WarrantsIssuedForAcquisition
0 usd
CY2024Q1 onfo Preferred Dividends
PreferredDividends
-81645 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-39134 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-630497 usd
CY2024Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
5229979 usd
CY2024Q2 onfo Acquisition Of Business Amount
AcquisitionOfBusinessAmount
400000 usd
CY2024Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
27510 usd
CY2024Q2 onfo Common Stock Issued For Exercise Of Options Amount
CommonStockIssuedForExerciseOfOptionsAmount
0 usd
CY2024Q2 onfo Preferred Dividends
PreferredDividends
-84468 usd
CY2024Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
15788 usd
onfo Payments On Note Payables Related Parties
PaymentsOnNotePayablesRelatedParties
-1000 usd
onfo Payments On Note Payables Related Parties
PaymentsOnNotePayablesRelatedParties
0 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
310025 usd
us-gaap Asset Acquisition Consideration Transferred
AssetAcquisitionConsiderationTransferred
1869000 usd
us-gaap Asset Acquisition Consideration Transferred
AssetAcquisitionConsiderationTransferred
0 usd
onfo Common Stock Options Issued For Acquisition
CommonStockOptionsIssuedForAcquisition
60000 usd
onfo Common Stock Options Issued For Acquisition
CommonStockOptionsIssuedForAcquisition
0 usd
onfo Non Controlling Interest Issued For Acquisitions
NonControllingInterestIssuedForAcquisitions
126000 usd
onfo Non Controlling Interest Issued For Acquisitions
NonControllingInterestIssuedForAcquisitions
0 usd
onfo Common Stock Issued For Conversion Of Stock Options
CommonStockIssuedForConversionOfStockOptions
20 usd
onfo Common Stock Issued For Conversion Of Stock Options
CommonStockIssuedForConversionOfStockOptions
0 usd
CY2024Q2 us-gaap Common Unit Authorized
CommonUnitAuthorized
5000000 shares
us-gaap Dividends
Dividends
101269 usd
us-gaap Payments Of Dividends
PaymentsOfDividends
109053 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
6219863 shares

Files In Submission

Name View Source Status
0001654954-24-010636-index-headers.html Edgar Link pending
0001654954-24-010636-index.html Edgar Link pending
0001654954-24-010636.txt Edgar Link pending
0001654954-24-010636-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
onfo-20240630.xsd Edgar Link pending
onfo_10q.htm Edgar Link pending
onfo_ex221.htm Edgar Link pending
onfo_ex311.htm Edgar Link pending
onfo_ex312.htm Edgar Link pending
onfo_ex321.htm Edgar Link pending
onfo_ex322.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
onfo-20240630_cal.xml Edgar Link unprocessable
onfo-20240630_def.xml Edgar Link unprocessable
onfo-20240630_lab.xml Edgar Link unprocessable
onfo-20240630_pre.xml Edgar Link unprocessable
onfo_10q_htm.xml Edgar Link completed
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable